|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.0381901
|
|
|
PWS
|
[NCBI]
|
0.01021052
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00856328
|
|
|
obesity
|
[NCBI]
|
0.00650079
|
|
|
NPY
|
[NCBI]
|
0.00594736
|
|
|
OB10P
|
[NCBI]
|
0.00569086
|
|
|
MEHMO
|
[NCBI]
|
0.00569086
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.00569086
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.0052157
|
|
|
WTS
|
[NCBI]
|
0.00426444
|
|
|
LEP
|
[NCBI]
|
0.00374754
|
|
|
BBS
|
[NCBI]
|
0.00332155
|
|
|
ALMS
|
[NCBI]
|
0.00317613
|
|
|
LEPR
|
[NCBI]
|
0.00298517
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.0028405
|
|
|
LPL
|
[NCBI]
|
0.002628793
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.00247874
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.00247874
|
|
|
COH1
|
[NCBI]
|
0.002187147
|
|
|
SHBG
|
[NCBI]
|
0.002143747
|
|
|
POMC
|
[NCBI]
|
0.002095918
|
|
|
MC4R
|
[NCBI]
|
0.001891753
|
|
|
FPLD1
|
[NCBI]
|
0.00188607
|
|
|
UCP1
|
[NCBI]
|
0.001825897
|
|
|
PPARA
|
[NCBI]
|
0.00157933
|
|
|
striae distensae, familial
|
[NCBI]
|
0.001419027
|
|
|
abdominal obesity-metabolic syndrome quantitative trait locus 2
|
[NCBI]
|
0.001419027
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.001419027
|
|
|
gallbladder disease 2
|
[NCBI]
|
0.001419027
|
|
|
circulating adiponectin quantitative trait locus on chromosome 5
|
[NCBI]
|
0.001419027
|
|
|
gallbladder disease 3
|
[NCBI]
|
0.001419027
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.001419027
|
|
|
anisomastia
|
[NCBI]
|
0.001419027
|
|
|
mental retardation, truncal obesity, retinal dystrophy, and micropenis
|
[NCBI]
|
0.001419027
|
|
|
coloboma-obesity-hypogenitalism-mental retardation syndrome
|
[NCBI]
|
0.001419027
|
|
|
circulating adiponectin quantitative trait locus on chromosome 14
|
[NCBI]
|
0.001419027
|
|
|
PMCH
|
[NCBI]
|
0.001371129
|
|
|
UCP2
|
[NCBI]
|
0.001168108
|
|
|
NIDDM
|
[NCBI]
|
0.001127768
|
|
|
GIP
|
[NCBI]
|
0.001106003
|
|
|
CCK
|
[NCBI]
|
0.001090591
|
|
|
RA
|
[NCBI]
|
0.001086906
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000941854
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000941854
|
|
|
MRXS7
|
[NCBI]
|
0.000941854
|
|
|
PYY
|
[NCBI]
|
0.000875388
|
|
|
PCOS1
|
[NCBI]
|
0.000796333
|
|
|
EGF
|
[NCBI]
|
0.000723379
|
|
|
MODY
|
[NCBI]
|
0.00071292
|
|
|
wagr syndrome
|
[NCBI]
|
0.000698776
|
|
|
ADRB3
|
[NCBI]
|
0.000683771
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000653059
|
|
|
body mass index
|
[NCBI]
|
0.000649189
|
|
|
acanthosis nigricans
|
[NCBI]
|
0.000647933
|
|
|
clark-baraitser syndrome
|
[NCBI]
|
0.000647063
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000608306
|
|
|
SLE
|
[NCBI]
|
0.000600293
|
|
|
PLIN
|
[NCBI]
|
0.000599239
|
|
|
INS
|
[NCBI]
|
0.00059034
|
|
|
proopiomelanocortin deficiency
|
[NCBI]
|
0.000588719
|
|
|
camera-marugo-cohen syndrome
|
[NCBI]
|
0.000588719
|
|
|
UCP3
|
[NCBI]
|
0.000575282
|
|
|
CF
|
[NCBI]
|
0.000574655
|
|
|
CPE
|
[NCBI]
|
0.000563466
|
|
|
VEGF
|
[NCBI]
|
0.000466491
|
|
|
INSIG2
|
[NCBI]
|
0.000461848
|
|
|
APOB
|
[NCBI]
|
0.000448623
|
|
|
PPARG
|
[NCBI]
|
0.000434663
|
|
|
ADIPOQ
|
[NCBI]
|
0.000432269
|
|
|
GHRL
|
[NCBI]
|
0.00042841
|
|
|
SCD
|
[NCBI]
|
0.000398866
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
0.000392377
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.000387046
|
|
|
EPO
|
[NCBI]
|
0.000371804
|
|
|
NGFB
|
[NCBI]
|
0.000359628
|
|
|
GAL
|
[NCBI]
|
0.0003593432
|
|
|
TUB
|
[NCBI]
|
0.000348139
|
|
|
AFP
|
[NCBI]
|
0.000344488
|
|
|
PCNA
|
[NCBI]
|
0.0003178178
|
|
|
RETN
|
[NCBI]
|
0.00030538
|
|
|
AHO
|
[NCBI]
|
0.000304747
|
|
|
CCKAR
|
[NCBI]
|
0.000303561
|
|
|
SLC2A4
|
[NCBI]
|
0.0003033438
|
|
|
AGRP
|
[NCBI]
|
0.000302266
|
|
|
MPO
|
[NCBI]
|
0.0002948034
|
|
|
IAPP
|
[NCBI]
|
0.000292887
|
|
|
RBP4
|
[NCBI]
|
0.000274646
|
|
|
intracranial hypertension, idiopathic
|
[NCBI]
|
0.000270896
|
|
|
FABP2
|
[NCBI]
|
0.000266851
|
|
|
BBS4
|
[NCBI]
|
0.000258411
|
|
|
KLK3
|
[NCBI]
|
0.0002577073
|
|
|
carpenter syndrome
|
[NCBI]
|
0.000257686
|
|
|
PTPN1
|
[NCBI]
|
0.0002477354
|
|
|
PNPLA2
|
[NCBI]
|
0.0002250819
|
|
|
GPR24
|
[NCBI]
|
0.0002250819
|
|
|
SLC6A14
|
[NCBI]
|
0.0002028535
|
|
|
GALP
|
[NCBI]
|
0.0001992764
|
|
|
GBD1
|
[NCBI]
|
0.0001982613
|
|
|
momo syndrome
|
[NCBI]
|
0.0001961378
|
|
|
prolactin deficiency with obesity and enlarged testes
|
[NCBI]
|
0.0001961378
|
|
|
SSOS
|
[NCBI]
|
0.0001961378
|
|
|
mental retardation, obesity, mandibular prognathism, and eye and skin anomalies
|
[NCBI]
|
0.0001961378
|
|
|
midface hypoplasia, obesity, developmental delay, and neonatal hypotonia
|
[NCBI]
|
0.0001961378
|
|
|
obesity-hypoventilation syndrome
|
[NCBI]
|
0.0001961378
|
|
|
hyperlipoproteinemia, type iv
|
[NCBI]
|
0.0001961378
|
|
|
ENPP1
|
[NCBI]
|
0.0001955047
|
|
|
ATHS
|
[NCBI]
|
0.0001893548
|
|
|
ALMS1
|
[NCBI]
|
0.0001876976
|
|
|
AQP7
|
[NCBI]
|
0.0001842996
|
|
|
CRH
|
[NCBI]
|
0.000177675
|
|
|
CFTR
|
[NCBI]
|
0.0001749111
|
|
|
ACACA
|
[NCBI]
|
0.0001748669
|
|
|
hyper-beta-alaninemia
|
[NCBI]
|
0.0001737296
|
|
|
biemond syndrome ii
|
[NCBI]
|
0.0001737296
|
|
|
MC3R
|
[NCBI]
|
0.0001728813
|
|
|
ACHE
|
[NCBI]
|
0.0001664179
|
|
|
FABP4
|
[NCBI]
|
0.0001657048
|
|
|
ADRB2
|
[NCBI]
|
0.0001624666
|
|
|
BFLS
|
[NCBI]
|
0.0001617171
|
|
|
GNB3
|
[NCBI]
|
0.0001614272
|
|
|
ASIP
|
[NCBI]
|
0.0001598057
|
|
|
IRS2
|
[NCBI]
|
0.0001573372
|
|
|
AR
|
[NCBI]
|
0.0001567596
|
|
|
MKKS
|
[NCBI]
|
0.0001521349
|
|
|
SDC3
|
[NCBI]
|
0.0001491953
|
|
|
mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor
|
[NCBI]
|
0.0001460538
|
|
|
b-cell immunodeficiency, distal limb anomalies, and urogenital malformations
|
[NCBI]
|
0.0001460538
|
|
|
SHEP9
|
[NCBI]
|
0.0001460538
|
|
|
hyperostosis frontalis interna
|
[NCBI]
|
0.0001460538
|
|
|
summitt syndrome
|
[NCBI]
|
0.0001460538
|
|
|
PTH
|
[NCBI]
|
0.0001460256
|
|
|
NMU
|
[NCBI]
|
0.0001445095
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
0.0001439822
|
|
|
MRXHF1
|
[NCBI]
|
0.0001422517
|
|
|
PBEF1
|
[NCBI]
|
0.000141434
|
|
|
abdominal body fat distribution
|
[NCBI]
|
0.0001356691
|
|
|
CNTF
|
[NCBI]
|
0.0001301035
|
|
|
proprotein convertase 1 deficiency
|
[NCBI]
|
0.0001289598
|
|
|
atkin-flaitz syndrome
|
[NCBI]
|
0.0001272513
|
|
|
alaninuria with microcephaly, dwarfism, enamel hypoplasia, and diabetes mellitus
|
[NCBI]
|
0.0001272513
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
0.0001272513
|
|
|
FPLD2
|
[NCBI]
|
0.0001254049
|
|
|
SGBS1
|
[NCBI]
|
0.0001241887
|
|
|
laurence-moon syndrome
|
[NCBI]
|
0.000120542
|
|
|
HGF
|
[NCBI]
|
0.0001202167
|
|
|
choroideremia with deafness and obesity
|
[NCBI]
|
0.0001150981
|
|
|
ADPN
|
[NCBI]
|
0.0001139519
|
|
|
ANGPTL4
|
[NCBI]
|
0.0001124691
|
|
|
CHAT
|
[NCBI]
|
0.0001109345
|
|
|
SQLE
|
[NCBI]
|
0.0001053853
|
|
|
GHRH
|
[NCBI]
|
0.0001036254
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
0.0001029032
|
|
|
acth deficiency
|
[NCBI]
|
0.0001009904
|
|
|
ADA
|
[NCBI]
|
0.0001006108
|
|
|
BBS2
|
[NCBI]
|
0.0001004144
|
|
|
TH
|
[NCBI]
|
9.98149e-05
|
|
|
PRLH
|
[NCBI]
|
9.78794e-05
|
|
|
HSD11B1
|
[NCBI]
|
9.49064e-05
|
|
|
FAAH
|
[NCBI]
|
9.45573e-05
|
|
|
lactic acidosis, fatal infantile
|
[NCBI]
|
9.40584e-05
|
|
|
FTO
|
[NCBI]
|
9.21336e-05
|
|
|
PPARGC1B
|
[NCBI]
|
9.21336e-05
|
|
|
SIM1
|
[NCBI]
|
9.11765e-05
|
|
|
IKBKB
|
[NCBI]
|
9.09114e-05
|
|
|
PPARD
|
[NCBI]
|
9.07216e-05
|
|
|
PRLHR
|
[NCBI]
|
8.8779e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
8.86363e-05
|
|
|
INSIG1
|
[NCBI]
|
8.62055e-05
|
|
|
CPAF
|
[NCBI]
|
8.56162e-05
|
|
|
ATP10A
|
[NCBI]
|
8.45715e-05
|
|
|
SERPINA6
|
[NCBI]
|
8.2624e-05
|
|
|
CD36
|
[NCBI]
|
8.22084e-05
|
|
|
GCCR
|
[NCBI]
|
8.18969e-05
|
|
|
IRS1
|
[NCBI]
|
8.17529e-05
|
|
|
G6PD
|
[NCBI]
|
7.58444e-05
|
|
|
ATS
|
[NCBI]
|
7.36093e-05
|
|
|
glycerol-3-phosphate acyltransferase 3
|
[NCBI]
|
7.2055e-05
|
|
|
NMUR2
|
[NCBI]
|
7.2055e-05
|
|
|
urb, mouse, homolog of
|
[NCBI]
|
7.2055e-05
|
|
|
obesity, susceptibility to, on chromosome 10q
|
[NCBI]
|
7.2055e-05
|
|
|
PTK2
|
[NCBI]
|
7.17809e-05
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
7.15989e-05
|
|
|
MKKS
|
[NCBI]
|
6.95998e-05
|
|
|
TNF
|
[NCBI]
|
6.798109e-05
|
|
|
ARMD4
|
[NCBI]
|
6.7683e-05
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
6.65885e-05
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
6.63492e-05
|
|
|
LIPC
|
[NCBI]
|
6.54857e-05
|
|
|
GDNF
|
[NCBI]
|
6.54088e-05
|
|
|
TTR
|
[NCBI]
|
6.43843e-05
|
|
|
PCSK1
|
[NCBI]
|
6.42412e-05
|
|
|
NMUR1
|
[NCBI]
|
6.38538e-05
|
|
|
SGIP1
|
[NCBI]
|
6.38538e-05
|
|
|
ACOT11
|
[NCBI]
|
6.38538e-05
|
|
|
CIDEA
|
[NCBI]
|
6.38538e-05
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
6.32883e-05
|
|
|
LBX2
|
[NCBI]
|
6.07873e-05
|
|
|
ELOVL6
|
[NCBI]
|
6.07873e-05
|
|
|
SCG3
|
[NCBI]
|
6.07873e-05
|
|
|
ATRN
|
[NCBI]
|
6.02004e-05
|
|
|
SLC4A5
|
[NCBI]
|
5.88122e-05
|
|
|
ANGPTL6
|
[NCBI]
|
5.88122e-05
|
|
|
GGPS1
|
[NCBI]
|
5.88122e-05
|
|
|
NR0B2
|
[NCBI]
|
5.86641e-05
|
|
|
ADIPOR1
|
[NCBI]
|
5.75053e-05
|
|
|
SLC27A5
|
[NCBI]
|
5.73554e-05
|
|
|
NPY2R
|
[NCBI]
|
5.73554e-05
|
|
|
ESRRA
|
[NCBI]
|
5.73554e-05
|
|
|
ADRA2B
|
[NCBI]
|
5.73554e-05
|
|
|
MCHR2
|
[NCBI]
|
5.73554e-05
|
|
|
AD
|
[NCBI]
|
5.70411e-05
|
|
|
GHSR
|
[NCBI]
|
5.59637e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
5.38736e-05
|
|
|
PHB
|
[NCBI]
|
5.32625e-05
|
|
|
AVP
|
[NCBI]
|
5.17117e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
5.14415e-05
|
|
|
MAPK8
|
[NCBI]
|
5.12774e-05
|
|
|
adipocyte-specific adhesion molecule
|
[NCBI]
|
5.02031e-05
|
|
|
STEAP4
|
[NCBI]
|
5.02031e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
4.8793e-05
|
|
|
PLTP
|
[NCBI]
|
4.85921e-05
|
|
|
PD
|
[NCBI]
|
4.78881e-05
|
|
|
MGRN1
|
[NCBI]
|
4.71366e-05
|
|
|
PLSCR3
|
[NCBI]
|
4.71366e-05
|
|
|
TULP3
|
[NCBI]
|
4.71366e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
4.69248e-05
|
|
|
PPARGC1A
|
[NCBI]
|
4.55996e-05
|
|
|
NUCB2
|
[NCBI]
|
4.51615e-05
|
|
|
RAB23
|
[NCBI]
|
4.51615e-05
|
|
|
GPR39
|
[NCBI]
|
4.51615e-05
|
|
|
TRIB3
|
[NCBI]
|
4.51615e-05
|
|
|
SORCS1
|
[NCBI]
|
4.37047e-05
|
|
|
TF
|
[NCBI]
|
4.32932e-05
|
|
|
VIP
|
[NCBI]
|
4.269164e-05
|
|
|
P2RX4
|
[NCBI]
|
4.25532e-05
|
|
|
HCRTR1
|
[NCBI]
|
4.25532e-05
|
|
|
RFWD2
|
[NCBI]
|
4.25532e-05
|
|
|
NEIL1
|
[NCBI]
|
4.25532e-05
|
|
|
NPY5R
|
[NCBI]
|
4.25532e-05
|
|
|
CTSK
|
[NCBI]
|
4.21241e-05
|
|
|
LIPE
|
[NCBI]
|
4.16035e-05
|
|
|
VDR
|
[NCBI]
|
4.12778e-05
|
|
|
TG
|
[NCBI]
|
4.095053e-05
|
|
|
NTRK2
|
[NCBI]
|
3.99151e-05
|
|
|
FCHL
|
[NCBI]
|
3.94562e-05
|
|
|
LMNA
|
[NCBI]
|
3.90003e-05
|
|
|
AIMAH
|
[NCBI]
|
3.87312e-05
|
|
|
TGFA
|
[NCBI]
|
3.86334e-05
|
|
|
CAPN10
|
[NCBI]
|
3.86126e-05
|
|
|
COMT
|
[NCBI]
|
3.85493e-05
|
|
|
DPP4
|
[NCBI]
|
3.79876e-05
|
|
|
SEPS1
|
[NCBI]
|
3.74819e-05
|
|
|
PLA2G1B
|
[NCBI]
|
3.74819e-05
|
|
|
F3
|
[NCBI]
|
3.70126e-05
|
|
|
NHLH2
|
[NCBI]
|
3.68424e-05
|
|
|
SLC6A3
|
[NCBI]
|
3.65516e-05
|
|
|
KCNA3
|
[NCBI]
|
3.65322e-05
|
|
|
FASN
|
[NCBI]
|
3.63294e-05
|
|
|
GALR2
|
[NCBI]
|
3.57258e-05
|
|
|
PROX1
|
[NCBI]
|
3.57258e-05
|
|
|
SH2B1
|
[NCBI]
|
3.57258e-05
|
|
|
lipin 1
|
[NCBI]
|
3.53856e-05
|
|
|
CCKBR
|
[NCBI]
|
3.50267e-05
|
|
|
RPS6KB1
|
[NCBI]
|
3.50267e-05
|
|
|
ACACB
|
[NCBI]
|
3.441076e-05
|
|
|
PON3
|
[NCBI]
|
3.42341e-05
|
|
|
VGF
|
[NCBI]
|
3.42341e-05
|
|
|
ARL6
|
[NCBI]
|
3.42341e-05
|
|
|
INPPL1
|
[NCBI]
|
3.38613e-05
|
|
|
CTSS
|
[NCBI]
|
3.38613e-05
|
|
|
ALB
|
[NCBI]
|
3.37084e-05
|
|
|
SGNE1
|
[NCBI]
|
3.32844e-05
|
|
|
H19
|
[NCBI]
|
3.30817e-05
|
|
|
MSTN
|
[NCBI]
|
3.301475e-05
|
|
|
PHF6
|
[NCBI]
|
3.3004e-05
|
|
|
GIPR
|
[NCBI]
|
3.2478e-05
|
|
|
CUL4B
|
[NCBI]
|
3.2478e-05
|
|
|
GCKR
|
[NCBI]
|
3.17789e-05
|
|
|
PLCB2
|
[NCBI]
|
3.17789e-05
|
|
|
CAT
|
[NCBI]
|
3.13851e-05
|
|
|
PTGER3
|
[NCBI]
|
3.116296e-05
|
|
|
RP
|
[NCBI]
|
3.07397e-05
|
|
|
INSR
|
[NCBI]
|
3.07161e-05
|
|
|
GATA2
|
[NCBI]
|
3.06135e-05
|
|
|
CTGF
|
[NCBI]
|
3.041189e-05
|
|
|
DGAT1
|
[NCBI]
|
3.011838e-05
|
|
|
SPP1
|
[NCBI]
|
2.96668e-05
|
|
|
FGF19
|
[NCBI]
|
2.93973e-05
|
|
|
CLOCK
|
[NCBI]
|
2.927772e-05
|
|
|
PF4
|
[NCBI]
|
2.883106e-05
|
|
|
PTPRF
|
[NCBI]
|
2.878136e-05
|
|
|
HCRT
|
[NCBI]
|
2.679365e-05
|
|
|
ABCC8
|
[NCBI]
|
2.652855e-05
|
|
|
SDC1
|
[NCBI]
|
2.6146e-05
|
|
|
CRLF1
|
[NCBI]
|
2.59913e-05
|
|
|
CPB2
|
[NCBI]
|
2.59332e-05
|
|
|
MAPK9
|
[NCBI]
|
2.58204e-05
|
|
|
CD
|
[NCBI]
|
2.56867e-05
|
|
|
AHSG
|
[NCBI]
|
2.56736e-05
|
|
|
EIF2S1
|
[NCBI]
|
2.54154e-05
|
|
|
XBP1
|
[NCBI]
|
2.54154e-05
|
|
|
IGF2
|
[NCBI]
|
2.524217e-05
|
|
|
GYS1
|
[NCBI]
|
2.48259e-05
|
|
|
SORBS1
|
[NCBI]
|
2.462494e-05
|
|
|
SLC27A1
|
[NCBI]
|
2.462494e-05
|
|
|
CNTFR
|
[NCBI]
|
2.38809e-05
|
|
|
GCK
|
[NCBI]
|
2.36728e-05
|
|
|
SIM2
|
[NCBI]
|
2.35807e-05
|
|
|
CFD
|
[NCBI]
|
2.35311e-05
|
|
|
HK2
|
[NCBI]
|
2.35311e-05
|
|
|
MAPK8IP1
|
[NCBI]
|
2.3361e-05
|
|
|
NCOA1
|
[NCBI]
|
2.3361e-05
|
|
|
SREBF1
|
[NCBI]
|
2.3361e-05
|
|
|
AS
|
[NCBI]
|
2.31369e-05
|
|
|
SOCS3
|
[NCBI]
|
2.303446e-05
|
|
|
XDH
|
[NCBI]
|
2.277542e-05
|
|
|
GNAQ
|
[NCBI]
|
2.25861e-05
|
|
|
MEST
|
[NCBI]
|
2.217448e-05
|
|
|
SLC2A2
|
[NCBI]
|
2.185237e-05
|
|
|
NPPA
|
[NCBI]
|
2.174087e-05
|
|
|
PIK3R1
|
[NCBI]
|
2.14452e-05
|
|
|
NCOA2
|
[NCBI]
|
2.094388e-05
|
|
|
LCAT
|
[NCBI]
|
2.086801e-05
|
|
|
TCF7L2
|
[NCBI]
|
2.08468e-05
|
|
|
CEBPA
|
[NCBI]
|
2.00038e-05
|
|
|
ABCC1
|
[NCBI]
|
1.993607e-05
|
|
|
MT1A
|
[NCBI]
|
1.970314e-05
|
|
|
DCTN1
|
[NCBI]
|
1.970314e-05
|
|
|
loc387715 gene
|
[NCBI]
|
1.930308e-05
|
|
|
ADRB1
|
[NCBI]
|
1.90271e-05
|
|
|
hypertension, essential
|
[NCBI]
|
1.868422e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
1.862598e-05
|
|
|
TULP1
|
[NCBI]
|
1.84871e-05
|
|
|
RAI1
|
[NCBI]
|
1.844158e-05
|
|
|
MDD
|
[NCBI]
|
1.823915e-05
|
|
|
CNR1
|
[NCBI]
|
1.81615e-05
|
|
|
APOM
|
[NCBI]
|
1.785781e-05
|
|
|
HTR2A
|
[NCBI]
|
1.764932e-05
|
|
|
ADHD
|
[NCBI]
|
1.749193e-05
|
|
|
NDN
|
[NCBI]
|
1.736347e-05
|
|
|
ADRP
|
[NCBI]
|
1.710055e-05
|
|
|
GAL3ST1
|
[NCBI]
|
1.708301e-05
|
|
|
IL6R
|
[NCBI]
|
1.67988e-05
|
|
|
PIK3CG
|
[NCBI]
|
1.668743e-05
|
|
|
DBH
|
[NCBI]
|
1.659472e-05
|
|
|
IRDN
|
[NCBI]
|
1.653201e-05
|
|
|
PRL
|
[NCBI]
|
1.627253e-05
|
|
|
CDO
|
[NCBI]
|
1.609485e-05
|
|
|
ALOX5
|
[NCBI]
|
1.605212e-05
|
|
|
ALDH1A1
|
[NCBI]
|
1.56331e-05
|
|
|
GATA3
|
[NCBI]
|
1.560766e-05
|
|
|
breast cancer
|
[NCBI]
|
1.560698e-05
|
|
|
menkes disease
|
[NCBI]
|
1.554575e-05
|
|
|
ACOX1
|
[NCBI]
|
1.540617e-05
|
|
|
BDNF
|
[NCBI]
|
1.528088323e-05
|
|
|
CBFA2T1
|
[NCBI]
|
1.516788e-05
|
|
|
SLC18A3
|
[NCBI]
|
1.5140374e-05
|
|
|
LHB
|
[NCBI]
|
1.47069e-05
|
|
|
CCL2
|
[NCBI]
|
1.460776e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.418118e-05
|
|
|
TLR4
|
[NCBI]
|
1.405945e-05
|
|
|
PON1
|
[NCBI]
|
1.392766e-05
|
|
|
MC1R
|
[NCBI]
|
1.366829e-05
|
|
|
SSTR2
|
[NCBI]
|
1.359574e-05
|
|
|
SCP2
|
[NCBI]
|
1.296549e-05
|
|
|
GAD2
|
[NCBI]
|
1.288611e-05
|
|
|
PIK3CA
|
[NCBI]
|
1.288011e-05
|
|
|
SOD1
|
[NCBI]
|
1.259148e-05
|
|
|
G6PC2
|
[NCBI]
|
1.258827e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.246636e-05
|
|
|
FOXC2
|
[NCBI]
|
1.200271e-05
|
|
|
MFN2
|
[NCBI]
|
1.158896e-05
|
|
|
PC
|
[NCBI]
|
1.145703e-05
|
|
|
JAK2
|
[NCBI]
|
1.113052e-05
|
|
|
GK
|
[NCBI]
|
1.091943e-05
|
|
|
ESR2
|
[NCBI]
|
1.091943e-05
|
|
|
CETP
|
[NCBI]
|
1.070197e-05
|
|
|
LRP5
|
[NCBI]
|
1.063696e-05
|
|
|
STAT3
|
[NCBI]
|
1.03769e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.034529e-05
|
|
|
CHGA
|
[NCBI]
|
1.017115e-05
|
|
|
IL6
|
[NCBI]
|
1.00001e-05
|
|
|
HMGA2
|
[NCBI]
|
9.61246e-06
|
|
|
PTPN11
|
[NCBI]
|
9.17566e-06
|
|
|
GRB2
|
[NCBI]
|
9.05806e-06
|
|
|
APOE
|
[NCBI]
|
9.0400074e-06
|
|
|
STAT5A
|
[NCBI]
|
8.2916e-06
|
|
|
BRCA1
|
[NCBI]
|
8.20691e-06
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
8.06232e-06
|
|
|
PGR
|
[NCBI]
|
7.9670418e-06
|
|
|
ACADS
|
[NCBI]
|
7.82245e-06
|
|
|
SMS
|
[NCBI]
|
7.79912e-06
|
|
|
TFPI
|
[NCBI]
|
7.60262e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
7.386896e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
7.221614e-06
|
|
|
ACE
|
[NCBI]
|
7.04195e-06
|
|
|
PAI1
|
[NCBI]
|
6.8903e-06
|
|
|
IL18
|
[NCBI]
|
6.8703e-06
|
|
|
ACH
|
[NCBI]
|
6.52819e-06
|
|
|
ENPP2
|
[NCBI]
|
6.03445e-06
|
|
|
IGFALS
|
[NCBI]
|
5.71742e-06
|
|
|
MMP3
|
[NCBI]
|
5.64715e-06
|
|
|
AKR1B1
|
[NCBI]
|
5.16143e-06
|
|
|
PAM
|
[NCBI]
|
5.1517704e-06
|
|
|
ASPA
|
[NCBI]
|
5.13663e-06
|
|
|
SDC2
|
[NCBI]
|
4.45726e-06
|
|
|
NFKB1
|
[NCBI]
|
4.4473e-06
|
|
|
GTS
|
[NCBI]
|
4.43171e-06
|
|
|
AGT
|
[NCBI]
|
4.27492e-06
|
|
|
BCHE
|
[NCBI]
|
4.125426e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.04753e-06
|
|
|
C3
|
[NCBI]
|
3.93329e-06
|
|
|
ATRX
|
[NCBI]
|
3.9103e-06
|
|
|
CEACAM1
|
[NCBI]
|
3.73752e-06
|
|
|
APCS
|
[NCBI]
|
3.71443e-06
|
|
|
AMH
|
[NCBI]
|
3.618087e-06
|
|
|
APOD
|
[NCBI]
|
3.487263e-06
|
|
|
EIG
|
[NCBI]
|
3.17301e-06
|
|
|
VASP
|
[NCBI]
|
3.085185e-06
|
|
|
A2M
|
[NCBI]
|
2.90115e-06
|
|
|
NR1I2
|
[NCBI]
|
2.8525886e-06
|
|
|
PNMT
|
[NCBI]
|
2.6522833e-06
|
|
|
MMP9
|
[NCBI]
|
2.231971e-06
|
|
|
HP
|
[NCBI]
|
1.989517e-06
|
|
|
SST
|
[NCBI]
|
1.84932e-06
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.801759e-06
|
|
|
MECP2
|
[NCBI]
|
1.7116758e-06
|
|
|
IFNA1
|
[NCBI]
|
1.655299e-06
|
|
|
GAPDH
|
[NCBI]
|
1.627899e-06
|
|
|
GNRH1
|
[NCBI]
|
1.585159e-06
|
|
|
TGFB1
|
[NCBI]
|
1.555428e-06
|
|
|
GPT
|
[NCBI]
|
1.514424e-06
|
|
|
DBI
|
[NCBI]
|
1.3741245e-06
|
|
|
BRCA2
|
[NCBI]
|
1.3704989e-06
|
|
|
von willebrand disease
|
[NCBI]
|
1.358179157e-06
|
|
|
STAT6
|
[NCBI]
|
1.334061e-06
|
|
|
IL10
|
[NCBI]
|
9.35611e-07
|
|
|
CRC
|
[NCBI]
|
9.351942e-07
|
|
|
WBS
|
[NCBI]
|
8.73811e-07
|
|
|
ABCB11
|
[NCBI]
|
6.67688e-07
|
|
|
KDR
|
[NCBI]
|
6.07014e-07
|
|
|
GH1
|
[NCBI]
|
5.92845e-07
|
|
|
GHR
|
[NCBI]
|
5.320213e-07
|
|
|
GIST
|
[NCBI]
|
4.791161e-07
|
|
|
HDC
|
[NCBI]
|
3.686864e-07
|
|
|
CFH
|
[NCBI]
|
3.2800876e-07
|
|
|
RTT
|
[NCBI]
|
3.229720919e-07
|
|
|
UCN
|
[NCBI]
|
2.9338917e-07
|
|
|
FRAP1
|
[NCBI]
|
2.5401861e-07
|
|
|
AIRE
|
[NCBI]
|
1.886997e-07
|
|
|
GNAS
|
[NCBI]
|
1.157551e-07
|
|
|
ESR1
|
[NCBI]
|
5.33003e-08
|
|